ESOPREVEG INJ

ESOPREVEG Injection contains Esomeprazole 40 mg, a proton pump inhibitor (PPI) used to reduce the production of stomach acid. It is indicated for the treatment of gastroesophageal reflux disease (GERD), gastric and duodenal ulcers, erosive esophagitis, and other acid-related disorders, especially when oral therapy is not suitable. It is also used for the prevention and treatment of stress-related gastric ulcers in hospitalized patients.

ESOPREVEG Injection provides rapid and effective acid suppression, promoting ulcer healing, relieving acid-related symptoms, and protecting the gastrointestinal tract from acid-induced damage.

Key Benefits

• Effectively reduces stomach acid production
• Promotes healing of gastric and duodenal ulcers
• Provides relief from GERD and acid reflux symptoms
• Helps treat erosive esophagitis
• Prevents stress-related gastric ulcers in critically ill patients
• Suitable when oral administration is not feasible